Dose-Ranging Trial Of Novavax Pandemic Flu Vaccine Demonstrates Immunogenicity
This article was originally published in The Pink Sheet Daily
Executive Summary
Firm says further development of vaccine for Indonesia 2005 strain requires either co-development partner or government contracts.
You may also be interested in...
PIPE Proceeds In Hand, Novavax Looks To Score With Two Late-Stage Flu Vaccines
Vaccine-focused biotech says it has sufficient cash to continue business strategy through third-quarter 2009.
PIPE Proceeds In Hand, Novavax Looks To Score With Two Late-Stage Flu Vaccines
Vaccine-focused biotech says it has sufficient cash to continue business strategy through third-quarter 2009.
FDA Starts Process For Regulating Next-generation Vaccine Adjuvants
Scientific meeting planned for late fall or early spring.